Top 10 Holdings
Here you can see the 10 largest positions of the L&G Pharma Breakthrough UCITS ETF.
| Name | Industry | Country | Weight | ||
|---|---|---|---|---|---|
| 1 | Xeris Biopharma Holdings Inc Healthcare | Healthcare | 5.22 % | ||
| 2 | Genmab A/S Healthcare | Healthcare | 3.99 % | ||
| 3 | Xencor Inc Healthcare | Healthcare | 3.39 % | ||
| 4 | United Therapeutics Corp Healthcare | Healthcare | 3.10 % | ||
| 5 | Biogen Inc. Healthcare | Healthcare | 2.98 % | ||
| 6 | BeOne Medicines Ltd ADR Healthcare | Healthcare | 2.95 % | ||
| 7 | AstraZeneca Healthcare | Healthcare | 2.90 % | ||
| 8 | Eisai Co. Ltd. Healthcare | Healthcare | 2.87 % | ||
| 9 | Royalty Pharma PLC Class A Healthcare | Healthcare | 2.81 % | ||
| 10 | Basilea Pharmaceutica Ltd Registered Shares Healthcare | Healthcare | 2.81 % | ||
Asset classes
Here you can see the asset classes of the L&G Pharma Breakthrough UCITS ETF.
Currencies
Here you can see the currency breakdown of L&G Pharma Breakthrough UCITS ETF.
Regions
Here you can see the regional breakdown.
Country allocation
This ETF invests in these countries L&G Pharma Breakthrough UCITS ETF.
Sectors
Here you can see the sector breakdown of L&G Pharma Breakthrough UCITS ETF.
Currencies
Here you can see the currency breakdown of L&G Pharma Breakthrough UCITS ETF.
Data as of: 18 Nov 2026
Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).
Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.
Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.